Editorial: Antituberculosis chemotherapy: a resume of the rationale.
D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006801:Humans; D007194:India; D007538:Isoniazid / Q000627:therapeutic use*; D012651:Self Medication; D013828:Thioacetazone / Q000627:therapeutic use*; D013997:Time Factors; D014376:Tuberculosis / Q000188:drug therapy*
D013828:Thioacetazone; D007538:Isoniazid